Upper extremity deep venous thrombosis after BNT162b2 mRNA COVID‐19 vaccine case report

We describe a case of an otherwise healthy 60‐year‐old female patient who presented 6 days after receipt of the second dose of the BNT162b2 mRNA COVID‐19 (Pfizer/BioNTech) vaccine and was found to have upper extremity deep venous thrombosis.

Detalles Bibliográficos
Autores principales: Gonzalez, Susan, Levine, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969541/
https://www.ncbi.nlm.nih.gov/pubmed/36860723
http://dx.doi.org/10.1002/ccr3.6012
Descripción
Sumario:We describe a case of an otherwise healthy 60‐year‐old female patient who presented 6 days after receipt of the second dose of the BNT162b2 mRNA COVID‐19 (Pfizer/BioNTech) vaccine and was found to have upper extremity deep venous thrombosis.

Ejemplares similares